Original title:Yuanda Pharmaceutical & Health (00512-HK)It is proposed to invest 50 million US dollars to invest 1Pharmaceutical funds

Yuanda Healthcare (00512-HK) announced that it will invest in a fund. The Group's proposed capital commitment is 50 million US dollars; the fund plans to raise a total of 200 million US dollars. The fund's investment scope and fields are highly compatible with the Group's development goals, that is, it mainly includes (but not limited to) world-leading investmentsPharmaceuticalsCompanies and pharmaceutical device manufacturers (mainly focused on biopharmaceuticals, cardiovascular, ophthalmology, oncology treatment and other fields).